Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-23

Clinical Trial Update: The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing glimepiride versus sitagliptin as add-on therapy to metformin in severe insulin-deficient type 2 diabetes; status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)
  • Sitagliptin (sitagliptin)
  • metformin (metformin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Diabetes Mellitus, Type 2, Severe Insulin Deficient Diabetes | Phase 4 | Status: UNKNOWN